Market Overview

Benzinga's Top Pre-Market Losers

Related RIGL
What You Need to Know About the Roche-InterMune Deal
InterMune's Roche Deal Sends Peer Group Up
Related ENDP
US Stock Futures Up Ahead Of Economic Data
UPDATE: FDA-Approved Product Further Expands Endo's Branded Pharmaceutical Men's Health Portfolio

Rigel Pharmaceuticals (NASDAQ: RIGL) shares fell 30.96% to $5.82 in the pre-market trading. Rigel Pharmaceuticals' trailing-twelve-month ROE is -45.82%.

Endo Health Solutions (NASDAQ: ENDP) shares dropped 6.38% to $25.84 in pre-market trading. Endo cut its earnings view for 2012 and 2013.

Ciena (NASDAQ: CIEN) dipped 1.73% to $15.30 in the pre-market session. Ciena posted a wider fiscal fourth-quarter loss.

Canadian Solar (NASDAQ: CSIQ) dipped 1.33% to $2.97 in the pre-market session. Canadian Solar named Guangchun Zhang as its Chief Operating Officer.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (CIEN + CSIQ)

Around the Web, We're Loving...

Get Benzinga's Newsletters